Pfizer Inc. has recalled Excede (ceftiofur crystalline free acid) sterile suspension, a veterinary antibiotic medication, after stability testing showed the drug was not releasing at the required rate. This recall affects the 100 ml bottle size (equivalent to 200 mg/mL ceftiofur) used in veterinary care. Because the medication may not release correctly from the injection site, it may not provide the intended level of treatment to the animal.
The product's rate of release fell below the specified limit during testing, which could result in the animal receiving the medication too slowly. This may lead to reduced efficacy in treating the underlying infection or condition for which it was prescribed.
Veterinary drug refund and professional consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response